Benzoquinone, a leukemogenic metabolite of benzene, catalytically inhibits the protein tyrosine phosphatase PTPN2 and alters STAT1 signaling

Supporting Information

Supporting Information (to be published online) - supplementary Figure 1 and 2 and supplementary table 1